Dexcel Pharma is a privately owned pharmaceutical company engaged in the development, manufacturing, and commercialization of innovative and generic drug products worldwide. The company emphasizes commitment to dream, develop, and deliver across therapeutic areas, with operations spanning research, manufacturing, and market access. Its global reach includes key markets in the United States, Israel, Germany, the United Kingdom, and Austria, supported by a diversified portfolio that includes branded prescription drugs, OTC products, and generics.